Well Health Technologies Stock Revenue
| WELL Stock | CAD 6.48 0.05 0.77% |
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 892.5 M | 937.1 M |
WELL | Revenue |
WELL Health Technologies Company Revenue Analysis
WELL Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current WELL Health Revenue | 776.05 M |
Most of WELL Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WELL Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of WELL
Projected quarterly revenue analysis of WELL Health Technologies provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of WELL Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in WELL Health's stock price.
WELL Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Revenue. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
WELL Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, WELL Health Technologies reported 776.05 M of revenue. This is 89.82% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all Canada stocks is 91.77% higher than that of the company.
WELL Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WELL Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WELL Health could also be used in its relative valuation, which is a method of valuing WELL Health by comparing valuation metrics of similar companies.WELL Health is currently under evaluation in revenue category among its peers.
WELL Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.1B | 937.3M | 626.8M | 910.7M | 819.6M | 860.6M | |
| Enterprise Value | 1.0B | 1.3B | 936.3M | 1.3B | 1.2B | 1.2B |
WELL Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0245 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.94 B | ||||
| Shares Outstanding | 248.96 M | ||||
| Shares Owned By Insiders | 21.31 % | ||||
| Shares Owned By Institutions | 5.97 % | ||||
| Number Of Shares Shorted | 1.56 M | ||||
| Price To Book | 1.90 X | ||||
| Price To Sales | 1.68 X | ||||
| Revenue | 776.05 M | ||||
| Gross Profit | 422.89 M | ||||
| EBITDA | 101.88 M | ||||
| Net Income | 82 K | ||||
| Cash And Equivalents | 48.91 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 426.28 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 3.40 X | ||||
| Cash Flow From Operations | 62.59 M | ||||
| Short Ratio | 1.01 X | ||||
| Earnings Per Share | 0.31 X | ||||
| Price To Earnings To Growth | (1.32) X | ||||
| Target Price | 8.57 | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 1.61 B | ||||
| Total Asset | 1.41 B | ||||
| Retained Earnings | (63.58 M) | ||||
| Working Capital | 23.44 M | ||||
| Net Asset | 1.41 B |
About WELL Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.